Crosstalk between the lncRNA UCA1 and microRNAs in cancer

被引:35
|
作者
Xuan, Wei [1 ]
Yu, Hongyu [2 ]
Zhang, Xiaoling [3 ,4 ]
Song, Dandan [5 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Hepatopancreaticobiliary Surg, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Hosp 2, Dept Nephrol, Changchun, Jilin, Peoples R China
[3] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
[4] Jilin Univ, Inst Immunol, Changchun, Jilin, Peoples R China
[5] Jilin Univ, Hosp 2, Dept Clin Lab, 218 Zigiang St, Changchun 130041, Jilin, Peoples R China
关键词
cancer; drug resistance; invasion; metabolism; micro RNA; proliferation; UCA1; LONG NONCODING RNA; COMPETING ENDOGENOUS RNA; RENAL-CELL CARCINOMA; ENHANCES TAMOXIFEN RESISTANCE; PAPILLARY THYROID-CARCINOMA; PREDICTS POOR-PROGNOSIS; BLADDER-CANCER; LUNG-CANCER; PROMOTES PROLIFERATION; CISPLATIN RESISTANCE;
D O I
10.1002/1873-3468.13470
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long non-coding RNAs (lncRNAs) are a major subset of highly conserved non-coding RNAs (ncRNAs) that consist of at least 200 nucleotides and have limited protein-coding potential. Cumulative data have shown that lncRNAs are deregulated in many types of cancer and may control pathophysiological processes of cancer at various levels, including transcription, post-transcription and translation. Recently, lncRNAs have been demonstrated to interact with microRNAs (miRNAs), another major subset of ncRNAs, which regulate physiological and pathological processes by inhibiting target mRNA translation or promoting mRNA degradation. The lncRNA urothelial carcinoma-associated 1 (UCA1) has recently gained much attention as it is overexpressed in many types of cancer and is involved in carcinogenesis. Here, we review the crosstalk between UCA1 and miRNAs during the pathogenesis of cancer, with a focus on cancer-cell proliferation, invasion, drug resistance, and metabolism.
引用
收藏
页码:1901 / 1914
页数:14
相关论文
共 50 条
  • [1] The prognostic value and mechanisms of lncRNA UCA1 in human cancer
    Yao, Fei
    Wang, Qiang
    Wu, Qingming
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7685 - 7696
  • [2] LncRNA UCA1 in anti-cancer drug resistance
    Wang, Haohao
    Guan, Zhonghai
    He, Kuifeng
    Qian, Jiong
    Cao, Jiang
    Teng, Lisong
    ONCOTARGET, 2017, 8 (38) : 64638 - 64650
  • [3] Differential expression profile analysis of lncRNA UCA1α regulated mRNAs in bladder cancer
    Wang, Yu
    Zhang, Hong
    Li, Xu
    Chen, Wei
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (02) : 1841 - 1854
  • [4] UCA1 lncRNA in metastases and prognosis
    Song, Wei
    Wang, Kai
    Zou, Shu-Bing
    PANMINERVA MEDICA, 2017, 59 (03) : 278 - 279
  • [5] The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review
    Sun, Cen-Cen
    Li, Li
    Jiang, Zhi-Chen
    Liu, Zheng-Chuang
    Wang, Liang
    Wang, Hui-Ju
    JOURNAL OF CANCER, 2023, 14 (02): : 275 - 280
  • [6] Expression of lncRNA UCA1 in ovarian cancer and its clinical significance
    Qiu, Y. R.
    Zhao, M. Y.
    Sun, L.
    Yang, B. C.
    Hei, K. W.
    Du, X.
    Li, Y. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 191 - 195
  • [7] Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer
    Avgeris, Margaritis
    Tsilimantou, Anastasia
    Levis, Panagiotis K.
    Rampias, Theodoros
    Papadimitriou, Maria-Alexandra
    Panoutsopoulou, Konstantina
    Stravodimos, Konstantinos
    Scorilas, Andreas
    CARCINOGENESIS, 2019, 40 (08) : 965 - 974
  • [8] Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
    Li, Wei
    Xie, Peng
    Ruan, Wen-hui
    JOURNAL OF BONE ONCOLOGY, 2016, 5 (02) : 80 - 85
  • [9] Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer
    Neve, Bernadette
    Jonckheere, Nicolas
    Vincent, Audrey
    Van Seuningen, Isabelle
    CANCERS, 2018, 10 (11)
  • [10] Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients
    Alkhathami, Ali G.
    Hadi, Abdul
    Alfaifi, Mohammed
    Alshahrani, Mohammad Yahya
    Verma, Amit Kumar
    Beg, Mirza Masroor Ali
    DISEASE MARKERS, 2022, 2022